Explore evidence

4 %Of the 99 HIV-exposed infants (HEIs), 4 (4.0%) had missing HIV DNA PCR test results in the register.

NigeriaVIH/sidaobserved January 2018 to January 2019published 2021Journal of tropical pediatricsPubMeddocument of 4 observations

788 samplesA total of 788 samples were collected from newly diagnosed HIV clients across 4 sites in Lagos and 3 sites in Benue between February and August 2018.

NigeriaVIH/sidaobserved 2018published 2025BMC health services researchPubMeddocument of 7 observations

7.2 %Among pregnant women in Jos, Nigeria, the prevalence of hepatitis B virus (HBV) was 7.2% among those without human immunodeficiency virus (HIV), during the period from 1 November 2017 to 30 April 2018.

Nigeriahépatite B · VIH/sidaobserved 1 November 2017 to 30 April 2018published 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument of 3 observations

24 daysMedian time to death was 24 days in HIV-infected subjects.

Nigeriacarcinome hépatocellulaire · VIH/sidapublished 2021Tropical medicine & international health : TM & IHPubMeddocument of 15 observations

64.3 %The prevalence of viral suppression was 64.3% among 1120 HIV/AIDS-eligible patients in a tertiary health facility in Northwestern Nigeria between January and December 2021.

NigeriaVIH/sidaobserved 2021published 2024Annals of African medicinePubMeddocument of 12 observations

5 casesAmong 35 suspected mpox cases in Rivers State, Nigeria, between October 21, 2021, and April 30, 2023, 5 (14.3%) had HIV infection.

Nigeriampox · VIH/sidaobserved October 21, 2021 to April 30, 2023published 2025The Pan African medical journalPubMeddocument of 11 observations

0.09 aORAdults on second-line antiretroviral regimen had an adjusted odds ratio of 0.09 for interruption of antiretroviral therapy.

NigeriaVIH/sidapublished 2021BMC public healthPubMeddocument of 12 observations

36.5 %A restrictive filling pattern was observed in 36.5% of the HIV group.

NigeriaVIH/sidapublished 2022BMC pediatricsPubMeddocument of 6 observations

25 %A weighted HIV prevalence of 25.0% was found among men who have sex with men in Nigeria.

NigeriaVIH/sidaobserved 2020published 2025Sexually transmitted infectionsPubMeddocument of 12 observations

87.5 %The majority of respondents from the north-east of Nigeria had good knowledge about ART, at 87.5%.

NigeriaVIH/sidapublished 2022African journal of AIDS research : AJARPubMeddocument of 4 observations

741.2 cells/mm³The mean CD4 lymphocyte count was 741.2 cells/mm³.

NigeriaVIH/sidapublished 2022The Pan African medical journalPubMeddocument of 8 observations

96,041 womenHoward University Global Initiative, Nigeria trained health care providers who served 96,041 women to prevent mother-to-child transmission of HIV.

NigeriaVIH/sidapublished 2025Currents in pharmacy teaching & learningPubMeddocument of 9 observations

3.8 odds_ratioHIV-exposed infants tested at ≤6 weeks of age had significantly greater odds of a negative HIV result (OR = 3.8) compared to those tested after 20 weeks of age in North-Central Nigeria from January 2015 through July 2017.

NigeriaVIH/sidaobserved January 2015 through July 2017published 2019AIDS research and therapyPubMeddocument of 8 observations

0.41 per_100_person-yearsThe weighted, adjusted HIV-1 incidence in Akwa Ibom state, Nigeria, was 0.41 per 100 person-years (95% CI 0.16 to 0.66) in 2017.

NigeriaVIH/sidaobserved 2017published 2021Journal of the International AIDS SocietyPubMeddocument of 9 observations

100 %Among HIV-1 infected individuals with plasma viral load (PVL) ≥10,001 copies/mL, EBNA IgG seropositivity was 100.0%.

NigeriaVIH/sida · virus Epstein-Barrpublished 2020Journal of immunoassay & immunochemistryPubMeddocument of 15 observations

16.7 percentage_pointsThe mean absolute difference in antiretroviral therapy (ART) coverage between LGAs within states in Nigeria was 16.7 percentage points based on data from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) conducted from July to December 2018.

NigeriaVIH/sidaobserved 2018published 2022PloS onePubMeddocument of 5 observations

The missed opportunity for HIV testing among antenatal care attendees ranged from 0.2% in Imo State to 25.2% in Kaduna State in Nigeria in 2019.

NigeriaVIH/sidaobserved 2019published 2023AIDS carePubMeddocument of 7 observations

27 %Compared to pre-fee patients, the post-fee period had a 27% decreased odds of optimal medication adherence (aOR = 0.73, 95%CI: 0.59–0.89).

NigeriaVIH/sidapublished 2020PloS onePubMeddocument of 9 observations

32.4 %Among HIV-1 infected individuals, the highest seropositivity for EBNA IgM antibody (32.4%) was observed in the age group 31–40 years.

NigeriaVIH/sida · virus Epstein-Barrpublished 2020Journal of immunoassay & immunochemistryPubMeddocument of 15 observations

16.7 %Among 414 HIV genotyped specimens, 16.7% contained at least 1 drug resistance mutation (DRM).

NigeriaVIH/sidaobserved 2020published 2026Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 5 observations

70 %The simplest definition resulted in 70% to 90% concordance with all other definitions.

NigeriaVIH/sidaobserved 2013–2017published 2020Journal of the International AIDS SocietyPubMeddocument of 3 observations

3.85 %Among HIV-positive patients in the study, the prevalence of HIV/HBV co-infection was 3.85% among females and 2.57% among males.

Nigeriahépatite B · VIH/sidaobserved 2019published 2020Journal of immunoassay & immunochemistryPubMeddocument of 9 observations

2.5 %Of 1650 key populations living with HIV with attrition in the KP-CBART programme, 2.5% (n = 41) died.

NigeriaVIH/sidapublished 2021PloS onePubMeddocument of 7 observations

3,458 patientsThis study included 3458 HIV patients enrolled in care at the University College Hospital's Antiretroviral Therapy (ART) clinic in Ibadan, Nigeria.

NigeriaVIH/sidapublished 2022International journal of STD & AIDSPubMeddocument of 4 observations

11 %Recent facility-based HIV testing uptake was higher among adolescents and young adults (AYA) with two sexual partners in the past 3 months by an unadjusted risk difference of 11%, compared to AYA with no recent sexual partners.

NigeriaVIH/sidapublished 2026AIDS (London, England)PubMeddocument of 7 observations